Stage of Heart Failure | ||||
---|---|---|---|---|
A | B | C | p | |
N (%) | 20 (3.9) | 264 (51.9) | 225 (44.2) | |
Age (years), mean (SD) | 56.3 (8.3) | 66.8 (8.2) | 68.1 (9.1) | <0.0011 |
Male sex, n (%) | 16 (80.0) | 221 (83.7) | 180 (80.0) | 0.5142 |
Time since index event (months), mean (SD) | 20.4 (8.6) | 20.8 (9.1) | 22.2 (8.7) | 0.1941 |
Index event | ||||
Acute, n (%) | 20 (100) | 259 (98.5) | 223 (99.6) | 0.9492 |
Primary CHD event, n (%) | 4 (20.0) | 71 (26.9) | 54 (24.0) | 0.6962 |
Affected vessels | ||||
Main left coronary artery, n (%) | 0 | 15 (6.8) | 18 (9.5) | 0.3642 |
LAD, n (%) | 11 (64.7) | 145 (65.9) | 140 (74.1) | 0.1712 |
RCX, n (%) | 9 (52.9) | 106 (48.2) | 93 (49.2) | 0.9122 |
RCA, n (%) | 7 (41.2) | 117 (53.2) | 96 (50.8) | 0.622 |
Number of affected vessels | 0.6992 | |||
1, n (%) | 9 (52.9) | 100 (45.5) | 85 (45.0) | |
2, n (%) | 6 (35.3) | 68 (30.9) | 62 (32.8) | |
3, n (%) | 2 (11.8) | 44 (20.0) | 40 (21.2) | |
Duration of CHD (years), median (IQR) | 2.0 (1.4–3.4) | 2.8 (1.9–10.1) | 2.9 (2.0–9.9) | 0.0273 |
Treatment for index event | 0.4172 | |||
Conservative, n (%) | 6 (30.0) | 38 (14.4) | 37 (16.4) | |
CABG, n (%) | 2 (10.0) | 45 (17.0) | 32 (14.2) | |
PCI, n (%) | 12 (60.0) | 181 (68.6) | 156 (69.3) | |
Cardiovascular risk factors and comorbidities | ||||
Smokinga, n (%) | 5 (25.0) | 27 (10.2) | 19 (8.4) | 0.0712 |
Obesityb, n (%) | 8 (40.0) | 96 (36.5) | 80 (35.9) | 0.9322 |
LDL > = 2.6 mmol/L, n (%) | 8 (44.4) | 123 (49.0) | 88 (41.9) | 0.3242 |
Hypertensionc, n (%) | 3 (15.0) | 128 (48.7) | 94 (41.8) | 0.0072 |
Diabetes melltiusd, n (%) | 7 (35.0) | 102 (38.8) | 87 (39.4) | 0.9472 |
Chronic kidney diseasee, n (%) | 1 (5.0) | 51 (19.3) | 76 (34.7) | <0.0012 |
Measurements | ||||
BMI (kg/m2), median (IQR) | 27.7 (25.1–33.5) | 28.4 (26.3–31.1) | 28.7 (26.1–31.1) | 0.9263 |
Systolic BP (mmHg), median (IQR) | 119 (114–128) | 138 (126–152) | 133 (123–148) | <0.0013 |
Diastolic BP (mmHg), median (IQR) | 75 (66–80) | 81 (73–88) | 80 (73–86) | 0.0173 |
Heart rate (min-1), median (IQR) | 57 (55–64) | 61 (56–69) | 63 (58–70) | 0.0153 |
Sinus rhythm, n (%) | 20 (100) | 238 (93.0) | 186 (90.7) | 0.3682 |
LDL Cholesterol (mmol/L), median (IQR) | 2.6 (2.2–3.4) | 2.6 (2.1–3.1) | 2.5 (2.0–3.1) | 0.6233 |
HbA1c (%), median (IQR) | 5.6 (5.3–6.0) | 5.7 (5.5–6.3) | 5.8 (5.4–6.2) | 0.3763 |
NT-proBNP (pg/mL), median (IQR) | 76 (35–146) | 146 (78.5–312.5) | 245 (113.3–626.8) | <0.0013 |
Hs-TnT (pg/mL), median (IQR) | 6.1 (5.4–18.5) | 8.8 (6.6–11.8) | 10.0 (7.1–14.9) | 0.0123 |